法国制药巨头赛诺菲(SNY)今日股价盘中大涨5.06%,引发市场广泛关注。主要原因如下:
一、2024财年财报和2025年指引利好。赛诺菲2024年第四季度销售额和每股收益均超出预期,显示公司业绩良好。同时公司给出2025年销售额将实现中到高个位数增长,业务每股收益将有低两位数增长的乐观指引。
二、公司宣布50亿欧元股票回购计划。赛诺菲将于2025年回购总计50亿欧元股票并注销,以提高每股收益并向投资者传达公司对核心药品业务的信心。
此外,公司专注加大在生物制药业务的投入,计划出售消费者健康业务;新冠疫苗Beyfortus和哮喘药物Dupixent等在全球市场表现亮眼,凸显公司在新药研发方面的实力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.